SCHEMBL258960

SCHEMBL258960

Cc1cc(=C(C#N)C#N)c(C)cc1=C(C#N)C#N

nearest known ligand 0.32

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.32
▸ ERBB2 P04626 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ RXFP1 Q9HBX9 1/20 0.30
▸ RCE1 Q9Y256 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14154041 0.89 — —
SCHEMBL6549783 0.87 TTR (0.34) —
SCHEMBL6549755 0.87 GABRA1 (0.33) ALDH1A1KDM4E
SCHEMBL6550709 0.87 MEN1 (0.30) —
SCHEMBL12567046 0.83 LMNA (0.32) EGFRALDH1A1LMNAKDM4E
SCHEMBL20867325 0.83 EGFR (0.39) EGFRALDH1A1LMNAHPGDKDM4E
SCHEMBL12445192 0.83 — —
SCHEMBL12217380 0.78 ALDH1A1 (0.34) ALDH1A1LMNAKDM4E
SCHEMBL24948916 0.74 MEN1 (0.30) LMNA
SCHEMBL8002605 0.72 ALDH1A1 (0.32) ALDH1A1KDM4ERXFP1RCE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115467090-A Nanofiber membrane based on organic charge transfer eutectic, preparation method and application 苏州大学 2022-12-13 — — CN claimed
EP-1882693-B1 Method and solution for growing a charge-transfer complex salt onto a metal surface IMEC (BE) 2012-11-14 — — EP claimed
EP-0540371-B1 Initiator for photopolymerization AUTEX INC (JP) 1997-12-17 — — EP claimed
US-5389700-A Complex of a charge transfer compound conisting of a biscyclopentadienyl iron compound and a quinoid and a salt AUTEX, INC. (JP) 1995-02-14 — — US claimed
US-5312913-A Complexes of electron donors and electron acceptors IDEMITSU KOSAN CO., LTD. (JP) 1994-05-17 — — US claimed
EP-0540371-A1 Initiator for photopolymerization AUTEX, INC. (JP) 1993-05-05 — — EP claimed
JP-61282363-A — — None — — JP disclosed
EP-4600326-A2 HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES UDC Ireland Limited (IE) 2025-08-13 — — EP disclosed
EP-3916822-B1 HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES UDC IRELAND LTD (IE) 2025-08-06 — — EP disclosed
US-12376484-B2 Heteroleptic carbene complexes and the use thereof in organic electronics BASF SE (DE) 2025-07-29 — — US disclosed
US-20250017099-A1 HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES UDC IRELAND LIMITED (IE) 2025-01-09 — — US disclosed
US-20240213499-A1 PRIMARY ALKALI METAL CELLS WITH GEMINAL DINITRILE ADDITIVES LITRONIK BATTERIETECHNOLOGIE GMBH (DE) 2024-06-27 — — US disclosed
US-20240130221-A1 HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS UDC IRELAND LIMITED (IE) 2024-04-18 — — US disclosed
US-5175280-A Electroconductive complexes; heat resistance IDEMITSU KOSAN CO., LTD. (JP) 1992-12-29 — — US disclosed
EP-0454874-A1 THIA- AND/OR SELENAFULVALENYL COMPOUND IDEMITSU KOSAN COMPANY LIMITED (JP) 1991-11-06 — — EP disclosed
JP-S61282363-A SUBSTITUTED TETRACYANOQUINODIMETHANE (TCNQ) COMPLEX WAKO PURE CHEM IND LTD 1986-12-12 — — JP disclosed
US-4594180-A Doping with a sulfonate compound SHOWA DENKO K.K. (JP) 1986-06-10 — — US disclosed
US-4487709-A (FUMING) NITRIC OR SULFURIC ACID, HALOALKYLSULFONATE, CHLORO- OR FLUOROSULFURIC ACID- SHOWA DENKO K.K. (JP) 1984-12-11 — — US disclosed
EP-0026234-B1 PROCESS FOR PREPARING HIGHLY CONDUCTIVE ACETYLENE HIGH POLYMER SHOWA DENKO KABUSHIKI KAISHA (JP) 1984-07-11 — — EP disclosed
EP-0026234-A1 PROCESS FOR PREPARING HIGHLY CONDUCTIVE ACETYLENE HIGH POLYMER SHOWA DENKO KABUSHIKI KAISHA (JP) 1981-04-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12376484-B2 Heteroleptic carbene complexes and the use thereof in organic electronics OCIAD2, OCIAD1, CLTB EGFR 4202/4885ERBB2 1941/4885ALDH1A1 3051/4885
US-20240130221-A1 HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS OCIAD2, OCIAD1, CLTB EGFR 4202/4885ERBB2 1941/4885ALDH1A1 3051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback